JANUMET 500 mg/1 (SITAGLIPTIN and METFORMIN HYDROCHLORIDE TABLET, FILM COATED) 500 mg/1

Janumet 500 mg/1 combines sitagliptin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

500 mg/1

Pack Size

4 POUCH in 1 CARTON (0006-0575-56) / 2 BLISTER PACK in 1 POUCH / 7 TABLET, FILM COATED in 1 BLISTER

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Janumet 500 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It works by increasing insulin sensitivity and reducing glucose production in the liver. This medication is often prescribed alongside diet and exercise to manage blood sugar levels effectively.

Side Effects

Common effects of Janumet 500 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting the medication. Some users may also experience headaches or upper respiratory infections. These effects are generally mild and temporary.

Precautions & Warnings

Janumet 500 mg/1 should be used with caution in individuals with kidney or liver issues. It is important to stay hydrated and monitor blood sugar levels regularly. Always consult a healthcare provider before starting or adjusting any medication.

Avoid Interactions

Janumet 500 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can also affect blood sugar levels and should be consumed with caution. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Janumet 500 mg/1 is used to improve blood sugar control in adults with type 2 diabetes, often alongside diet and exercise.

Janumet 500 mg/1 is taken orally, typically with meals, as directed by a healthcare provider.

Common side effects may include nausea, diarrhea, and headaches, which are usually mild and temporary.

Janumet 500 mg/1 may interact with other medications, so it's important to consult a healthcare provider before combining it with other drugs.

Janumet 500 mg/1 is not suitable for everyone, especially those with certain kidney or liver conditions. Always consult a healthcare provider for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.